Subscription and demo access


 
About Interfax
Press Releases
Products & Services
Contact us
Customer Login
 


Headlines
 

04/20 09:31   Excess oil stockpiles on market could disappear in next few months - minister
 
04/20 09:30   Russia fulfilling OPEC+ at 99%, to reach 100% by month's end - minister
 
04/20 09:29   Access restricted to 18 VPNs, proxy services offering access to Telegram - Roskomnadzor
 
04/20 09:23   No dangerous items found in Russian Foreign Ministry HQ after phoned-in bomb threat - police
 
04/20 09:22   ROSKOMNADZOR BLOCKS 18 VPN AND PROXY SERVICES OFFERING ACCESS TO TELEGRAM - REGULATOR'S PRESS SERVICE
 
04/20 09:15   Police detain 16 demonstrators in Yerevan
 
04/20 09:14   Moscow press review for April 20, 2018
 
04/20 09:00   RUSSIA AND FSU GENERAL NEWS
 
04/20 08:15   Results of forex trading on Moscow Exchange on April 19
 
04/20 05:05   Russia political and economic calendar: April 20
 


 

Interfax.com  |  Interfax news  |  Pharmstandard, Millhouse close deal to acquire...


News headlines


July 25, 2014 09:25

Pharmstandard, Millhouse close deal to acquire stakes in Biocad Holding

MOSCOW. July 25 (Interfax) - Pharmstandard (MOEX: PHST), a major Russian drug maker, and Millhouse have completed individual acquisitions of shares in Biocad Holding Ltd., the principal shareholder of St. Petersburg-based biotech company CJSC Biocad, the companies said in a joint statement.

Pharmstandard acquired a 20% stake in Biocad Holding Ltd., while a company affiliated with Millhouse acquired 50%.

Pharmstandard financed the acquisition with its own money, the press release states.

Biocad CEO and founder Dmitry Morozov will retain a 30% stake in Biocad Holding Ltd and will continue to run the company with his management team, the statement said.

Biocad develops, manufactures and promotes its own and generic drugs to treat illnesses in the areas of urology, gynecology, dermatovenereology, oncology and hematology, as well as autoimmune and infectious diseases. The company has a line of 14 drugs.

"Millhouse and Pharmstandard have a successful track record of working together to develop leaders in the pharmaceutical market. The companies previously cooperated on the acquisitions of ICN Pharmaceuticals, Inc. and CJSC Masterlek, and on Pharmstandard's initial public offering," the press release said.

It was reported earlier that in this deal the companies would buy the stake of Gazprombank (MOEX: GZPR), which acquired a controlling stake in the pharmaceutical company in 2011 for about $250 million-$300 million, as well as part of the stake held by company management.

RMG senior analyst Ksenia Arutyunova valued all of Biocad at $1 billion. Therefore, the stakes acquired by Pharmstandard and Millhouse are worth $200 million and $500 million respectively.

Millhouse is acting as a financial investor, who will divest the stake at some point, Arutyunova said, adding that this stake could be bought by Pharmstandard.

Biocad currently sells its products in Russia and other CIS countries. The company has offices in Ukraine, Belarus, Brazil, China, India and the United States. Biocad is also setting up production of drugs based on monoclonal antibodies in Brazil.

Biocad has two factories in Russia - in the Moscow Region and in the St. Petersburg special economic zone. The company had revenue of 3 billion rubles in 2013.

It was reported earlier that U.S. drug makers Pfizer and Amgen were interested in buying Biocad. The company was valued at $0.75 billion-$1 billion.

Vp of

(Our editorial staff can be reached at eng.editors@interfax.ru)

/Interfax/
 Subscription
You can access a demo version of, receive more information about or subscribe to Interfax publications by filling in and returning the form below. We also have dozens of reports in the Russian language, please indicate if you are interested.
Title:


Phone:


E-mail:


First name:


Company:


Country:
Last name:


Division:


City:
Products:
Central Asia & Caucasus Business Weekly
Central Asia General Newswire
Global Gas Analytics
Global Natural Gas Daily
Interfax Via Bloomberg Terminal
Kazakhstan General Newswire
Kazakhstan Mining Weekly
Kazakhstan Oil & Gas Weekly
Russia & CIS Announcements
Russia & CIS Banking and Finance Weekly
Russia & CIS Business and Financial Daily
Russia & CIS Business and Financial Newswire
Russia & CIS Business and Investment Weekly
Russia & CIS Business Law Weekly
Russia & CIS Business news
Russia & CIS Defense Industry Weekly
Russia & CIS Diplomatic Panorama
Russia & CIS Energy Daily
Russia & CIS Energy Newswire
Russia & CIS Events Calendar
Russia & CIS Food and Agriculture Weekly
Russia & CIS General Newswire
Russia & CIS Headline News
Russia & CIS Insurance Weekly
Russia & CIS IT and Telecom Weekly
Russia & CIS Metals and Mining Weekly
Russia & CIS Military Daily
Russia & CIS Military Newswire
Russia & CIS Military Weekly
Russia & CIS Oil and Gas Weekly
Russia & CIS Presidential Bulletin
Russia & CIS Statistics Weekly
Russia Health & Pharmaceuticals
Russia Market Roundup
Russia Press Review
Ukraine Business Daily
Ukraine Business Weekly
Ukraine General Newswire
Please enter the digits from picture in the box below:

April 20, 2018
 
09:22
ROSKOMNADZOR BLOCKS 18 VPN AND PROXY SERVICES OFFERING ACCESS TO TELEGRAM - REGULATOR'S PRESS SERVICE
 
09:15
Police detain 16 demonstrators in Yerevan
 
09:14
 
09:00
RUSSIA AND FSU GENERAL NEWS
 
08:15
Results of forex trading on Moscow Exchange on April 19
 
05:05
Russia political and economic calendar: April 20
 
05:00
INTERFAX RUSSIA AND CIS BUSINESS AND FINANCIAL NEWS
 
April 19, 2018
 
22:29
Ukraine's court announces start of debate in Yanukovych trial, defense attorneys protesting
 
22:04
London should allow Russian doctors to examine Yulia Skripal - Russian embassy
 
21:37
Volker should engage in constructive search for mutually acceptable solutions in Donbas - Russian Foreign Ministry
 
21:33
Fifty to seventy women, supposedly Russian nationals, over 100 children remain in Iraqi prison - Russian Foreign Ministry (Part 2)
 
21:25
Moscow reserves right to perform direct action if Ukraine does not let Nord vessel crew go home - Russian Foreign Ministry
 
21:14
Russia, U.S. could end up without direct flights because of visa problems for Aeroflot crews - Russian Foreign Ministry (Part 2)
 
21:06
Russia, U.S. could end up without direct flights because of visa problems for Aeroflot crews - Russian Foreign Ministry
 
 more headlines 



Interviews
 

.
The director of the Executive Committee of the SCO Regional Anti-Terrorist Structure, Yevgeny Sysoyev, gave an interview to Interfax in which he discussed threats that Russia and the world face in the light of ISILs transformation, as well as the structures achievements in the fight against terrorism.

more
.
.
Ahead of his visit to Moscow newly-elected Austrian Chancellor Sebastian Kurz has given an interview to Olga Golovanova for Interfax. In the interview he speaks about his expectations from the upcoming meeting with the Russian president, his vision of solving the energy-security problem in Europe, the migration crisis, and explains conditions under which some sanctions could be lifted from Russia.

more
.
.
Palestinian Ambassador to Russia Abdel Hafiz Nofal has given an interview to Interfax correspondent Veronika Vishnyakova ahead of a visit of Palestinian leader Mahmoud Abbas to Russia in which he speaks about the main topics of the upcoming Russian-Palestinian summit, prospects for the Palestinian-Israeli settlement and the initiative of creating a new mediating mechanism for the Palestinian-Israeli settlement.

more

 
  
 ©   1991—2018   Interfax Information Service. All rights reserved.
contact information   |   Interfax offices   |   made by web.finmarket

News and other data on this site are provided for information purposes only, and are not intended for republication or redistribution. Republication or redistribution of Interfax content, including by framing or similar means, is expressly prohibited without the prior written consent of Interfax.

Browse other Interfax sites:  Interfax.ru   |   IFX.RU   |   Interfax Group   Rambler's Top100